Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, intermediate-risk cervical carcinoma indicated that the addition of chemotherapy did not improve outcomes for patients and led to increased toxicity for patients.
No Change in Huntington’s Motor Symptoms With Investigational Drug
Investigational laquinimod did not change motor symptoms of Huntington’s disease after 1 year but did significantly reduce caudate volume loss compared with placebo, the phase
February 9, 2024